Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study
Open Access
- 11 July 2022
- journal article
- research article
- Published by Springer Nature in Translational Psychiatry
- Vol. 12 (1) , 1-8
Abstract
Concurrent anxiety is frequent in major depressive disorder and a shared pathophysiological mechanism between anxiety and other depressive symptoms is plausible. The serotonin 4 receptor (5-HT4R) has been implicated in both depression and anxiety. This is the first study to investigate the association between the cerebral 5-HT4R binding and anxiety in patients with depression before and after antidepressant treatment and the association to treatment response. Ninety-one drug-free patients with depression were positron emission tomography scanned with the 5-HT4R ligand [11C]-SB207145. Depression severity and concurrent anxiety was measured at baseline and throughout 8 weeks of antidepressant treatment. Anxiety measures included four domains: anxiety/somatization factor score; Generalized Anxiety Disorder 10-items (GAD-10) score; anxiety/somatization factor score ≥7 (anxious depression) and syndromal anxious depression. Forty patients were rescanned at week 8. At baseline, we found a negative association between global 5-HT4R binding and both GAD-10 score (p < 0.01) and anxiety/somatization factor score (p = 0.06). Further, remitters had a higher baseline anxiety/somatization factor score compared with non-responders (p = 0.04). At rescan, patients with syndromal anxious depression had a greater change in binding relative to patients with non-syndromal depression (p = 0.04). Concurrent anxiety in patients with depression measured by GAD-10 score and anxiety/somatization factor score is negatively associated with cerebral 5-HT4R binding. A lower binding may represent a subtype with reduced natural resilience against anxiety in a depressed state, and concurrent anxiety may influence the effect on the 5-HT4R from serotonergic antidepressants. The 5-HT4R is a promising neuroreceptor for further understanding the underpinnings of concurrent anxiety in patients with depression.Keywords
This publication has 51 references indexed in Scilit:
- Mass dose effects and in vivo affinity in brain PET receptor studies — a study of cerebral 5-HT4 receptor binding with [11C]SB207145Nuclear Medicine and Biology, 2011
- Age and sex effects on 5-HT4receptors in the human brain: A [11C]SB207145 PET studyJournal of Cerebral Blood Flow & Metabolism, 2011
- Central serotonin transporter levels are associated with stress hormone response and anxietyPsychopharmacology, 2010
- Brain imaging of serotonin 4 receptors in humans with [11C]SB207145-PETNeuroImage, 2010
- Diagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR )2010
- Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetineCurrent Medical Research and Opinion, 2010
- Kinetic Modeling of 11C-SB207145 Binding to 5-HT4 Receptors in the Human Brain In VivoJournal of Nuclear Medicine, 2009
- Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET studyMolecular Psychiatry, 2008
- Rapid Automated Algorithm for Aligning and Reslicing PET ImagesJournal of Computer Assisted Tomography, 1992
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960